TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 7 | 1 | 3 | 28 | 58 | 85 | 74 | 41 |
P | %wins | 57 | 57 | 71 | 57 | 100 | 86 | 71 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/8/16 16:11 | 2/5/16 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP of Sa | P | 37 | 24.75 | 33 | 2 | 11 | 16 | D | -24 | -53 | -56 | -46 | -39 | -27 | -10 | -2 | 4 | 8 | -3 | -23 | 36 | -13 |
12/13/13 11:15 | 12/13/13 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP | P | 3 | 27.43 | 12 | 0 | 0 | 59 | D | 637 | 473 | 141 | 57 | 19 | 0 | -12 | -10 | 4 | 10 | 29 | 55 | 69 | 55 |
5/18/10 16:17 | 5/17/10 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP | P | 3 | 4.70 | 0 | 1 | 2 | 39 | D | 29 | -24 | -25 | 12 | 2 | 5 | 11 | -6 | 0 | -2 | 3 | -12 | 15 | 9 |
11/25/08 19:06 | 11/25/08 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP | P | 3 | 1.66 | 0 | 2 | 86 | 4 | D | -71 | -50 | -50 | -42 | -11 | -34 | -29 | -17 | -3 | -2 | 82 | 183 | 198 | 221 |
11/24/08 17:37 | 11/21/08 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP | P | 4 | 2.10 | 0 | 2 | 595 | 2 | D | -69 | -46 | -45 | -35 | -7 | -25 | -21 | -9 | -3 | -7 | 69 | 149 | 186 | 202 |
5/26/06 13:05 | 5/24/06 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | O | VP | P | 2 | 6.55 | 0 | 0 | 27 | 1 | -2 | 2 | -7 | -15 | 11 | 8 | |||||||||
9/13/05 16:23 | 9/13/05 | LCI | Lannett Co Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Kevin | PA | H | Vice Pre | P | 4 | 4.38 | 0 | 1 | 999% | 1 | D | -77 | -59 | -33 | -10 | -14 | -6 | -8 | -6 | 9 | 13 | 21 | 66 | 78 | 34 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |